RiverPark Advisors’s GeneDx Holdings WGS Stock Holding History

RiverPark Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,146	Closed	-$149K	–	169
2025 Q4	$149K	Sell	1,146 -431	-27%	-$59.2K	0.04%	99
2025 Q3	$170K	Sell	1,577 -444	-22%	-$48.4K	0.07%	79
2025 Q2	$187K	Sell	2,021 -2,349	-54%	-$184K	0.11%	78
2025 Q1	$387K	Buy	4,370 +1,339	+44%	+$116K	0.3%	54
2024 Q4	$233K	Buy	+3,031	New	+$212K	0.19%	78
2021 Q1	–	Sell	-427	Closed	-$156K	–	144
2020 Q4	$156K	Buy	+427	New	+$149K	0.03%	92

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RiverPark Advisors's WGS Position: Q1 2026 in Review

RiverPark Advisors sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 1,146 shares — an estimated $149K sold.

RiverPark Advisors first reported a position in WGS in Q4 2020 and held it in 6 quarters. The position peaked at $387K in Q1 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

RiverPark Advisors reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
RiverPark Advisors sold 1,146 GeneDx Holdings shares in Q1 2026, an estimated $149K.
RiverPark Advisors first reported a position in GeneDx Holdings in Q4 2020 and held it in 6 quarters.
RiverPark Advisors's GeneDx Holdings position peaked at $387K in Q1 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.